Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Glaukos Corp (NY: GKOS ) 120.73 +2.02 (+1.70%) Official Closing Price Updated: 7:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Glaukos Corp < Previous 1 2 3 Next > Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31 July 10, 2024 From Glaukos Corporation Via Business Wire Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock June 14, 2024 From Glaukos Corporation Via Business Wire Glaukos Announces Participation in Upcoming Investor Conferences May 28, 2024 From Glaukos Corporation Via Business Wire Glaukos Announces First Quarter 2024 Financial Results May 01, 2024 From Glaukos Corporation Via Business Wire Glaukos Announces the Release of its 2023 Sustainability Report April 16, 2024 From Glaukos Corporation Via Business Wire Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1 April 10, 2024 From Glaukos Corporation Via Business Wire Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant) April 03, 2024 From Glaukos Corporation Via Business Wire Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting April 01, 2024 From Glaukos Corporation Via Business Wire Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results February 21, 2024 From Glaukos Corporation Via Business Wire Glaukos to Release Fourth Quarter and Full Year 2023 Financial Results after Market Close on February 21 January 31, 2024 From Glaukos Corporation Via Business Wire Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance January 09, 2024 From Glaukos Corporation Via Business Wire Glaukos Announces Participation in the J.P. Morgan Healthcare Conference December 20, 2023 From Glaukos Corporation Via Business Wire Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant) December 14, 2023 From Glaukos Corporation Via Business Wire Glaukos Announces Participation in Stifel Healthcare Conference November 07, 2023 From Glaukos Corporation Via Business Wire Glaukos Announces Third Quarter 2023 Financial Results November 01, 2023 From Glaukos Corporation Via Business Wire Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Academy of Ophthalmology Annual Meeting October 31, 2023 From Glaukos Corporation Via Business Wire Glaukos to Release Third Quarter 2023 Financial Results after Market Close on November 1, 2023 October 11, 2023 From Glaukos Corporation Via Business Wire Glaukos Announces Participation in Wells Fargo Healthcare Conference August 23, 2023 From Glaukos Corporation Via Business Wire Glaukos Announces Second Quarter 2023 Financial Results August 02, 2023 From Glaukos Corporation Via Business Wire Glaukos Enters into a Collaboration and Marketing Agreement with Radius XR, Inc. July 17, 2023 From Glaukos Corporation Via Business Wire Glaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023 July 12, 2023 From Glaukos Corporation Via Business Wire Glaukos Achieves Pipeline Milestone with Enrollment Completion in Phase 3 Confirmatory Trial for Epioxa (Epi-on) June 05, 2023 From Glaukos Corporation Via Business Wire Glaukos Announces Participation in the William Blair Growth Stock Conference May 24, 2023 From Glaukos Corporation Via Business Wire Glaukos Announces FDA Acceptance of NDA Submission for iDose TR May 05, 2023 From Glaukos Corporation Via Business Wire Glaukos Announces First Quarter 2023 Financial Results May 03, 2023 From Glaukos Corporation Via Business Wire Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting May 01, 2023 From Glaukos Corporation Via Business Wire Glaukos Announces the Release of its 2022 Sustainability Report April 19, 2023 From Glaukos Corporation Via Business Wire Glaukos to Release First Quarter 2023 Financial Results after Market Close on May 3 April 12, 2023 From Glaukos Corporation Via Business Wire Glaukos Submits New Drug Application to U.S. FDA for iDose TR February 27, 2023 From Glaukos Corporation Via Business Wire Glaukos Announces Fourth Quarter and Full Year 2022 Financial Results February 22, 2023 From Glaukos Corporation Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.